Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

June’s top stories: NIH’s neuroimaging study for autism, Philips’ €1.9bn purchase of Spectranetics

A new study by the University of North Carolina and Washington University School of Medicine demonstrated the use of the fcMRI technique to predict the risk for autism in infants, and Royal Philips signed an agreement to buy Spectranetics. wraps-up the key headlines from June 2017.

Go Top